The UAE is preparing to become the first country to approve a new oral treatment for vitiligo. This was announced by Dr. Ayman Alnaim, President of the Emirates Dermatology Society, during the opening of the 10th Conference of the Medical Association of the Emirates Dermatology Department, held on Friday, November 6.
The event is taking place at the InterContinental Dubai–Festival City hotel and is gathering over 500 doctors and specialists from around the world. Over three days, participants will study the latest advancements in dermatology, including the application of artificial intelligence, clinical imaging, and new therapeutic methods.
Vitiligo is a skin condition that causes a loss of skin color or pigment, making it lighter than its natural shade or causing whitening. It occurs when the body's immune system destroys melanocytes—skin cells that produce melanin, a chemical substance that gives skin its color or pigmentation.
In his welcoming speech, Dr. Alnaim noted that the conference will serve as a platform for the official launch of vitiligo treatment, as well as for announcing a range of new dermatological therapy methods, including the newest generation of biological agents for treating psoriasis and other diseases. This further strengthens the UAE's status as a global center for medical and pharmaceutical innovations.
He emphasized that the UAE is among the fastest countries in registering new drugs, providing patients with access to the most modern treatment methods. Furthermore, the country is one of the first in the world to use artificial intelligence technologies for diagnosing skin diseases such as psoriasis and skin cancer, and it also uses lasers to treat vascular moles, pigmentation, and benign tumors.
Dr. Alnaim stated: 'We are proud to host this scientific event in the United Arab Emirates, which continues to strengthen its position as a leading destination for innovation, knowledge exchange, and excellence in the healthcare sector.'
This year's conference agenda will cover a wide range of topics, including skin aging, eczema—one of the most common conditions, acne, skin cancer, and infectious and inflammatory skin diseases. Innovations in dermatology, such as AI applications, clinical imaging, and groundbreaking treatment approaches, will also be presented.



